Points International Ltd. Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 08, 2017 21:06 pm UTC| Business
– Full Year Revenue of $321.8 Million Increases 9% and Gross Profit of $43.3 Million Increases 2% Year-over-year – Full Year Net Income of $3.5 Million, before the impact of an impairment loss of $5.0 Million, Decreases...
Mar 08, 2017 21:05 pm UTC| Business
–Event-Driven 2017 Includes MAA Filing for IV Eravacycline in Europe and Top-Line Data Readout from IGNITE4 in cIAI – – Company to Host Conference Call Today, March 8, 2017 at 4:30 p.m. ET – WATERTOWN, Mass., March 08,...
Mar 08, 2017 21:05 pm UTC| Business
BURLINGTON, Mass., March 08, 2017 -- Exa® Corporation (NASDAQ:EXA), a global innovator in simulation software for product engineering, today announced that it will release its financial results for the fourth quarter...
Sunrun Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 08, 2017 21:05 pm UTC| Business
Revenues of $454 million in 2016, 49% Year-Over-Year Growth Net Present Value created of $213 million in 2016, an increase of 64% Year-Over-Year Net Earning Assets reach $1 billion, 30% Year-Over-Year Growth SAN...
LeMaitre Vascular to Present at the 29th Annual ROTH Conference on Tuesday, March 14, 2017
Mar 08, 2017 21:05 pm UTC| Business
BURLINGTON, Mass., March 08, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman CEO, will present at 29th Annual ROTH Conference on Tuesday, March 14, 2017 at the...
Twin Disc, Inc. Announces Multiple Orders for Oil and Gas Transmission Systems
Mar 08, 2017 21:05 pm UTC| Business
One Hundred Unit Pressure Pumping Transmission System Order ReceivedCompany Experiencing Sustained Recovery in Oil and Gas Aftermarket Activity RACINE, Wis., March 08, 2017 -- Twin Disc, Inc. (NASDAQ:TWIN), today...
Novelion Therapeutics Announces Presentation at the 29th Annual ROTH Conference
Mar 08, 2017 21:05 pm UTC| Business
VANCOUVER, British Columbia and CAMBRIDGE, Mass., March 08, 2017 -- Novelion Therapeutics, Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living...